Stryker (SYK) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8636671013

Stryker Corporation is a medical technology company traded on the New York Stock Exchange under the ticker symbol SYK. The company has two main operating segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.

The Orthopaedics and Spine segment specializes in providing implants for procedures like hip and knee replacements, as well as surgeries involving trauma and extremities. It also offers spinal implant products used in spinal injury, deformity, and degenerative therapies.

On the other hand, the MedSurg and Neurotechnology segment focuses on surgical equipment, surgical navigation systems, endoscopic devices, patient handling equipment, and various other medical device products used across different medical specialties.

Stryker brings innovative neurotechnology products to the market for minimally invasive endovascular techniques, brain surgeries, orthobiologic and biosurgery procedures, and treatments for stroke. Additionally, they offer craniomaxillofacial implant products for cranial, maxillofacial, and chest wall surgeries, among others.

The company operates globally, distributing its products to healthcare professionals and facilities in about 75 countries through a mix of company-owned subsidiaries, branches, and third-party dealers. Founded in 1941, Stryker Corporation is based in Kalamazoo, Michigan.

For more information, you can visit their website at https://www.stryker.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Stryker (SYK) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Stryker (SYK) - Stock Price & Dividends

SYK Stock Overview

Market Cap in USD 132,168m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1988-02-01

SYK Stock Ratings

Growth 5y 6.91
Fundamental 5.79
Dividend 6.96
Rel. Performance vs Sector 0.79
Analysts 4.03/5
Fair Price Momentum 317.94 USD
Fair Price DCF 230.51 USD

SYK Dividends

Yield 12m 0.95%
Yield on Cost 5y 1.80%
Dividends CAGR 5y 7.39%
Payout Consistency 93.4%

SYK Growth Ratios

Growth 12m 9.51%
Growth Correlation 12m 42%
Growth Correlation 3m 31%
CAGR 5y 13.67%
Sharpe Ratio 12m 0.21
Alpha vs SP500 12m -16.77
Beta vs SP500 5y weekly 1.18
ValueRay RSI 2.27
Volatility GJR Garch 1y 19.26%
Price / SMA 50 -6.24%
Price / SMA 200 8.18%
Current Volume 2143.6k
Average Volume 20d 1036.7k

External Links for SYK Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of SYK stocks?
As of April 19, 2024, the stock is trading at USD 327.45 with a total of 2,143,604 shares traded.
Over the past week, the price has changed by -5.44%, over one month by -7.31%, over three months by +4.28% and over the past year by +13.72%.
What is the forecast for SYK stock price target?
According to ValueRays Forecast Model, SYK Stryker will be worth about 354 in April 2025. The stock is currently trading at 327.45. This means that the stock has a potential upside of +8.12%.
Issuer Forecast Upside
Wallstreet Target Price 364.2 11.2%
Analysts Target Price 317.1 -3.16%
ValueRay Target Price 354 8.12%

Stryker Corporation: From Humble Beginnings to Global Leader

Stryker Corporation, globally recognized by its ticker symbol NYSE:SYK, stands out as one of the top-tier medical technology companies worldwide. The company's journey, its diverse product offerings, and its remarkable standing in the current market showcase its dedication to improving healthcare through innovative solutions.

History: The Foundation of Stryker

Stryker's story begins in 1941, with its founder, Dr. Homer Stryker, an orthopedic surgeon frustrated by the limitations of medical equipment available at the time. His inventions, aimed at addressing these challenges, laid the foundation for Stryker Corporation. The company's early focus was on creating products that enhanced patient and hospital outcomes, a core principle that continues to drive its operations.

Core Business: Advancing Medical Technology

At its heart, Stryker specializes in a wide array of medical technologies, including orthopedics, medical and surgical equipment, and neurotechnology and spine products. Its portfolio spans from joint replacement solutions and surgical equipment to neurovascular therapies and advanced wound care. This diverse range of products underscores Stryker's commitment to innovation and its role in supporting healthcare professionals and patients alike.

Side Business: Diversification and Growth

Beyond its primary offerings, Stryker has also strategically expanded into related areas. These include emergency medical services, digital solutions for surgery, and hospital information systems. This diversification not only broadens Stryker's impact across the healthcare sector but also enhances its resilience and adaptability in a constantly evolving market.

Current Market Status: A Leader Among Giants

Today, Stryker's standing in the global medical technology market is both prominent and influential. With a strong growth trajectory, the company continues to deliver on its commitment to innovation, garnering global recognition and a robust financial performance. Stryker's strategic acquisitions and a focus on research and development have further solidified its market position, making it a preferred partner for healthcare facilities and professionals worldwide.